Mimod 25 mg (Iguratimod)
| Active Ingredient | Iguratimod 25 |
|---|---|
| Indication: | Rheumatoid arthritis |
| Manufacturer: | Ajanta Pharma Ltd |
| Packaging | 15 Tablets in strip |
| Strength | 25mg |
| Delivery Time | 6 To 15 days |
Mimod 25mg contains Iguratimod, a novel disease-modifying antirheumatic drug (DMARD) used in the treatment of rheumatoid arthritis. It works by suppressing inflammatory cytokines and immune cell activity, helping reduce joint inflammation, pain, and stiffness in chronic autoimmune conditions.
Unlike traditional NSAIDs, Iguratimod offers long-term control by targeting the disease mechanism, not just the symptoms. It is often prescribed when other DMARDs or biologics are not effective or well-tolerated. Mimod 25 mg helps slow joint damage and improves overall mobility and quality of life in patients with rheumatoid arthritis.
Common side effects may include digestive issues, mild liver enzyme elevation, or rash. Regular monitoring is advised during treatment. Mimod 25 mg provides a promising option for managing moderate to severe rheumatoid arthritis with improved tolerability and sustained relief.








There are no reviews yet.